755P Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H).
Saved in:
| Title: | 755P Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H). |
|---|---|
| Authors: | Berton-Rigaud, D.1 (AUTHOR), Pautier, P.2 (AUTHOR), Lorusso, D.3 (AUTHOR), Gennigens, C.4 (AUTHOR), Gladieff, L.5 (AUTHOR), Kryzhanivska, A.6 (AUTHOR), Bowman, J.7 (AUTHOR), Tian, C.8 (AUTHOR), Cornfeld, M.7 (AUTHOR), Van Gorp, T.9 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS517-S517. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173098782 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 755P Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Berton-Rigaud%2C+D%2E%22">Berton-Rigaud, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pautier%2C+P%2E%22">Pautier, P.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gennigens%2C+C%2E%22">Gennigens, C.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gladieff%2C+L%2E%22">Gladieff, L.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kryzhanivska%2C+A%2E%22">Kryzhanivska, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bowman%2C+J%2E%22">Bowman, J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tian%2C+C%2E%22">Tian, C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cornfeld%2C+M%2E%22">Cornfeld, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Gorp%2C+T%2E%22">Van Gorp, T.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS517-S517. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173098782 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.1934 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S517 Titles: – TitleFull: 755P Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Berton-Rigaud, D. – PersonEntity: Name: NameFull: Pautier, P. – PersonEntity: Name: NameFull: Lorusso, D. – PersonEntity: Name: NameFull: Gennigens, C. – PersonEntity: Name: NameFull: Gladieff, L. – PersonEntity: Name: NameFull: Kryzhanivska, A. – PersonEntity: Name: NameFull: Bowman, J. – PersonEntity: Name: NameFull: Tian, C. – PersonEntity: Name: NameFull: Cornfeld, M. – PersonEntity: Name: NameFull: Van Gorp, T. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
